DNA methylation-independent reversion of gemcitabine resistance by hydralazine in cervical cancer cells.

MLA

Candelaria, Myrna, et al. “DNA Methylation-Independent Reversion of Gemcitabine Resistance by Hydralazine in Cervical Cancer Cells.” PloS One, vol. 7, no. 3, 2012, p. e29181. EBSCOhost, https://doi.org/10.1371/journal.pone.0029181.

APA

Candelaria, M., de la Cruz-Hernandez, E., Taja-Chayeb, L., Perez-Cardenas, E., Trejo-Becerril, C., Gonzalez-Fierro, A., Chavez-Blanco, A., Soto-Reyes, E., Dominguez, G., Trujillo, J. E., Diaz-Chavez, J., & Duenas-Gonzalez, A. (2012). DNA methylation-independent reversion of gemcitabine resistance by hydralazine in cervical cancer cells. PloS One, 7(3), e29181. https://doi.org/10.1371/journal.pone.0029181

Chicago

Candelaria, Myrna, Erick de la Cruz-Hernandez, Lucia Taja-Chayeb, Enrique Perez-Cardenas, Catalina Trejo-Becerril, Aurora Gonzalez-Fierro, Alma Chavez-Blanco, et al. 2012. “DNA Methylation-Independent Reversion of Gemcitabine Resistance by Hydralazine in Cervical Cancer Cells.” PloS One 7 (3): e29181. doi:10.1371/journal.pone.0029181.